Mechanism of anaphylactoid reactions: Improper preparation of high-dose intravenous cyclosporine leads to bolus infusion of Cremophor EL and cyclosporine

Annals of Pharmacotherapy

Volumn 31, Issue 11, 1997, Pages 1287-1291

  Liau Chu, Merry ^a   Theis, Jochen G W ^a   Koren, Gideon ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Anaphylaxis; Cyclosporine; Intravenous infusion; Multiple drug resistance

Indexed keywords

CREMOPHOR; CYCLOSPORIN; CYCLOSPORIN A;

ANAPHYLAXIS; ARTICLE; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CYANOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; ERYTHEMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIDRUG RESISTANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SPECTROPHOTOMETRY; SYMPTOMATOLOGY; TACHYCARDIA;

EID: 0030669929     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703101101     Document Type: Article

References (18)

1. Theis JGW, Liau-Chu M, Chan HSL, Doyle J, Greenberg ML, Koren G. Anaphylactoid reactions in children receiving high dose intravenous cyclosporine A for reversal of tumor resistance; the causative role of improper dissolution of Cremophor EL. J Clin Oncol 1995;13:2508-16.
2. American Pharmaceutical Association and The Pharmaceutical Society of Great Britain. Handbook of pharmaceutical excipients. Washington, DC: American Pharmaceutical Association, 1986:221-4.
3. Cremophor EL: technical leaflet. Dusseldorf: BASF, 1986.
4. Giesbrecht EE, Soldin SJ, Wong PY. A rapid, reliable high-performance liquid chromatographic micromethod for the measurement of cyclosporine in whole blood. Ther Drug Monit 1989;11:332-6.
5. Clarke RSJ. Hypersensitivity to intravenous anaesthetics. In: Dundee JW, Wyant GM, eds. Intravenous anaesthesia. London: Churchill Livingstone, 1988:248-71.
6. McEvoy GK, ed. American Hospital Formulary Service: drug information. Bethesda, MD: American Society of Hospital Pharmacists, 1993.
7. Dorr RT. Pharmacology and toxicology of Cremophor EL diluent. Ann Pharmacother 1994;28(suppl):S11-34.
8. Watt JM. Anaphylactic reaction after use of CT 1341 (Althesin). Br Med J 1979;3:205-6.
9. Avery AF, Evans A. Reactions to Althesin. Br J Anaesth 1973;45:301-2.
10. Christmas D. Immune reaction to propanidid. Anaesthesia 1984;39:470-3.
11. 1 and anaphylactic shock (letter). DICP Ann Pharmacother 1991;25:871-2.
12. Donehower RC, Rowinsky EK, Grochow LB, Longnecker SM, Ettinger DS. Phase I trial of taxol in patients with advanced cancer. Cancer Treat Rep 1987;71:1171-7.
13. Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, et al. Hypersensitivity reactions from Taxol. J Clin Oncol 1990;8: 1263-8.
14. Siddall SJ, Martin J, Nunn AJ. Anaphylactic reactions to teniposide (letter). Lancet 1989;1:394.
15. Stewart JA, Low JB, Roberts JD, Blow A. A Phase I clinical trial of didemnin B. Cancer 1991;68:2550-4.
16. Lassus M, Scott D, Leyland-Jones B. Allergic reactions associated with Cremophor containing antineoplastics (abstract). Proc Am Soc Clin Oncol 1985;4:268.
17. Weiss RB. Hypersensitivity reactions. Semin Oncol 1992;19:458-77.
18. Reynolds JEF, ed. Martindale: the extra pharmacopoeia. 30th ed. London: The Pharmaceutical Press, 1993.